Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1256]
News [2396]
Articles [92]
Editorials [4]
Conferences [118]
elearning [25]
Treatment of granulomatous mastitis
Dr Alajmi Adil Aljarrah - Sultan Qaboos University Hospital, Muscat, Sultanate...
Treatment of granulomatous mastitis ( Dr Alajmi Adil Aljarrah - Sultan Qaboos University Hospital, Muscat, Sultanate of Oman )
25 Jul 2013
Developments with PD1 and immunotherapy in melanoma
Prof Lex Eggermont – Institut Gustave Roussy, Villejuif, France
Developments with PD1 and immunotherapy in melanoma ( Prof Lex Eggermont – Institut Gustave Roussy, Villejuif, France )
19 Jul 2013
Battling therapeutic resistance
Dr Gerald Batist - McGill University, Montreal, Canada
Battling therapeutic resistance ( Dr Gerald Batist - McGill University, Montreal, Canada )
19 Jul 2013
Improving predictability of clinical trial outcomes
Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada
Improving predictability of clinical trial outcomes ( Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada )
18 Jul 2013
Advances in treatment of triple negative breast cancer
Dr Clifford Hudis - Memorial Sloan-Kettering Cancer Center, New York, USA
Advances in treatment of triple negative breast cancer ( Dr Clifford Hudis - Memorial Sloan-Kettering Cancer Center, New York, USA )
15 Jul 2013
Inclusion of adjuvant chemotherapy in luminal breast cancer
Dr Marco Colleoni - European Institute of Oncology
Inclusion of adjuvant chemotherapy in luminal breast cancer ( Dr Marco Colleoni - European Institute of Oncology )
15 Jul 2013
Anaemia update from EHA 2013
Prof Valeria Santini – University of Florence, Italy
Anaemia update from EHA 2013 ( Prof Valeria Santini – University of Florence, Italy )
28 Jun 2013
Rituximab for b-cell lymphoma and EHA overview
Prof Ulrich Jäger - EHA President and Vienna Medical University, Austria
Rituximab for b-cell lymphoma and EHA overview ( Prof Ulrich Jäger - EHA President and Vienna Medical University, Austria )
19 Jun 2013
Highlights from EHA 2013
Prof Anton Hagenbeek - Universitair Medisch Centrum Utrecht, Heidelberglaan...
Highlights from EHA 2013 ( Prof Anton Hagenbeek - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands )
19 Jun 2013
Second line treatment of multiple myeloma with melphalan prednisone and...
Prof Meletios Dimopoulos - Univeristy of Athens, Greece
Second line treatment of multiple myeloma with melphalan prednisone and lenalidomide ( Prof Meletios Dimopoulos - Univeristy of Athens, Greece )
19 Jun 2013
Challenges facing haematologists treating acute myeloid leukaemia
Dr Dalia Mahmoud - Celgene Corporation, Summit, USA
Challenges facing haematologists treating acute myeloid leukaemia ( Dr Dalia Mahmoud - Celgene Corporation, Summit, USA )
19 Jun 2013
Cyclophosphamide lenalidomide and dexamethasone in newly diagnosed myeloma
Dr Annamaria Brioli - The Institute of Cancer Research, Sutton, UK
Cyclophosphamide lenalidomide and dexamethasone in newly diagnosed myeloma ( Dr Annamaria Brioli - The Institute of Cancer Research, Sutton, UK )
19 Jun 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation